Watchlist Price Alert

Bicara Therapeutics Inc. ... (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

9.37

-0.30 (-3.10%)

At close: Jun 18, 2025, 1:35 PM

Bicara Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Net Income	-90.06M	-68M	-59.48M	-64.84M	-58.41M	-51.98M	-39.55M	-16.7M	-8.35M
Depreciation & Amortization	62K	56K	55K	42K	30.5K	19K	5K	3K	1.5K
Stock-Based Compensation	9.76M	7.4M	4.98M	3.47M	2.68M	1.9M	1.13M	615K	307.5K
Other Working Capital	-14.01M	-14.16M	776K	1.07M	786.5K	502K	-2.44M	-880K	-440K
Other Non-Cash Items	-127K	-46K	911K	14.2M	9.07M	3.94M	3.26M	-10.1M	-5.05M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-14.01M	-14.16M	776K	1.07M	786.5K	502K	-2.44M	-880K	-440K
Operating Cash Flow	-89.11M	-74.75M	-52.76M	-46.06M	-45.85M	-45.63M	-37.59M	-27.06M	-13.53M
Capital Expenditures	-59.5K	-71K	-467K	-609K	-597.5K	-586K	-150K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	31K	62K	62K	62K	31K	n/a	n/a	n/a	n/a
Investing Cash Flow	-28.5K	-9K	-405K	-547K	-566.5K	-586K	-150K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	335.11M	335.08M	335.01M	955K	19.47M	37.98M	37.98M	37.89M	18.95M
Financial Cash Flow	334.06M	334.03M	529.71M	235.47M	253.99M	272.5M	77.79M	37.89M	18.95M
Net Cash Flow	258.21M	285.86M	503.13M	215.45M	230.44M	230.44M	44.21M	14.99M	n/a
Free Cash Flow	-89.17M	-74.82M	-53.22M	-46.67M	-46.44M	-46.21M	-37.74M	-27.06M	-13.53M